Literature DB >> 12183169

Immunotherapy as a means to induce transplantation tolerance.

Scott H Adler1, Laurence A Turka.   

Abstract

There have been several recent advances in the use of immunotherapy to induce transplantation tolerance. These include newer and safer protocols to create hematopoietic chimerism, the development of more-powerful T cell depleting antibodies, the identification of additional costimlulatory pathways as molecular targets and the identification of a role for suppressor cells in transplant tolerance.

Mesh:

Substances:

Year:  2002        PMID: 12183169     DOI: 10.1016/s0952-7915(02)00376-x

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  3 in total

1.  Intravenous apoptotic spleen cell infusion induces a TGF-beta-dependent regulatory T-cell expansion.

Authors:  F Kleinclauss; S Perruche; E Masson; M de Carvalho Bittencourt; S Biichle; J-P Remy-Martin; C Ferrand; M Martin; H Bittard; J-M Chalopin; E Seilles; P Tiberghien; P Saas
Journal:  Cell Death Differ       Date:  2006-01       Impact factor: 15.828

2.  Questioning four preconceived ideas on immunotherapy of clinical type 1 diabetes: lessons from recent CD3 antibody trials.

Authors:  Lucienne Chatenoud; Jean-François Bach
Journal:  Rev Diabet Stud       Date:  2005-11-10

3.  CD28/CD154 blockade prevents autoimmune diabetes by inducing nondeletional tolerance after effector t-cell inhibition and regulatory T-cell expansion.

Authors:  Mark R Rigby; Alison M Trexler; Thomas C Pearson; Christian P Larsen
Journal:  Diabetes       Date:  2008-05-20       Impact factor: 9.461

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.